<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Drug Repurposing - Comprehensive Guide</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: Aptos, 'Segoe UI', sans-serif;
            background: #f5f5f5;
            padding: 40px 20px;
        }
        
        .container {
            max-width: 1200px;
            margin: 0 auto;
            background: white;
            padding: 60px;
            border-radius: 12px;
            box-shadow: 0 4px 20px rgba(0,0,0,0.1);
        }
        
        .main-title {
            font-size: 48px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 20px;
            text-align: center;
            border-bottom: 4px solid #1E64C8;
            padding-bottom: 20px;
        }
        
        .subtitle {
            font-size: 20px;
            color: #666;
            text-align: center;
            margin-bottom: 50px;
        }
        
        .content-grid {
            display: flex;
            flex-direction: column;
            gap: 22px;
            margin-bottom: 60px;
        }
        
        .content-card {
            background: #f8f9fa;
            border-left: 4px solid #1E64C8;
            border-radius: 8px;
            padding: 18px 24px;
            transition: all 0.3s;
            cursor: pointer;
        }
        
        .content-card:hover {
            background: #e8f2ff;
            transform: translateX(5px);
            box-shadow: 0 4px 12px rgba(30, 100, 200, 0.15);
        }
        
        .content-main {
            font-size: 20px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 6px;
        }
        
        .content-desc {
            font-size: 16px;
            color: #555;
            font-weight: 400;
        }
        
        .section {
            margin-bottom: 80px;
            page-break-inside: avoid;
        }
        
        .section-title {
            font-size: 32px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 30px;
            padding-bottom: 15px;
            border-bottom: 3px solid #1E64C8;
        }
        
        .section-content {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 40px;
            align-items: start;
        }
        
        .diagram {
            background: #f8f9fa;
            border-radius: 12px;
            padding: 30px;
            min-height: 300px;
            display: flex;
            flex-direction: column;
            justify-content: center;
            border: 2px solid #e0e0e0;
        }
        
        .description {
            padding: 20px;
        }
        
        .description h3 {
            font-size: 22px;
            color: #1E64C8;
            margin-bottom: 15px;
        }
        
        .description p {
            font-size: 16px;
            line-height: 1.8;
            color: #333;
            margin-bottom: 15px;
        }
        
        .key-points {
            background: #fff8e1;
            border-left: 4px solid #ffc107;
            padding: 15px 20px;
            margin-top: 20px;
            border-radius: 4px;
        }
        
        .key-points h4 {
            color: #f57c00;
            margin-bottom: 10px;
            font-size: 18px;
        }
        
        .key-points ul {
            margin-left: 20px;
        }
        
        .key-points li {
            margin-bottom: 8px;
            color: #555;
            line-height: 1.6;
        }
        
        .example-box {
            background: #e8f5e9;
            border-left: 4px solid #4caf50;
            padding: 15px 20px;
            margin-top: 15px;
            border-radius: 4px;
        }
        
        .example-box h4 {
            color: #2e7d32;
            margin-bottom: 8px;
            font-size: 18px;
        }
        
        .example-box p {
            color: #555;
            font-size: 15px;
            margin: 0;
        }
        
        /* Visual diagram elements */
        .flow-diagram {
            display: flex;
            flex-direction: column;
            gap: 15px;
        }
        
        .flow-box {
            background: white;
            border: 2px solid #1E64C8;
            border-radius: 8px;
            padding: 15px;
            text-align: center;
            font-weight: 600;
            color: #1E64C8;
            position: relative;
        }
        
        .flow-arrow {
            text-align: center;
            color: #1E64C8;
            font-size: 24px;
        }
        
        .network-diagram {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 20px;
            padding: 20px;
        }
        
        .network-node {
            background: white;
            border: 3px solid #1E64C8;
            border-radius: 50%;
            width: 80px;
            height: 80px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 12px;
            font-weight: 600;
            color: #1E64C8;
            text-align: center;
            margin: 0 auto;
        }
        
        .central-node {
            grid-column: 2;
            background: #1E64C8;
            color: white;
            width: 100px;
            height: 100px;
            font-size: 14px;
        }
        
        .signature-grid {
            display: grid;
            grid-template-columns: 1fr auto 1fr;
            gap: 20px;
            align-items: center;
            padding: 20px;
        }
        
        .signature-box {
            background: white;
            border: 2px solid #1E64C8;
            border-radius: 8px;
            padding: 20px;
            text-align: center;
        }
        
        .signature-title {
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 10px;
            font-size: 16px;
        }
        
        .gene-list {
            font-size: 12px;
            color: #666;
            line-height: 1.6;
        }
        
        .match-symbol {
            font-size: 36px;
            color: #4caf50;
            font-weight: 700;
        }
        
        .timeline {
            display: flex;
            justify-content: space-between;
            align-items: center;
            padding: 30px 0;
            position: relative;
        }
        
        .timeline::before {
            content: '';
            position: absolute;
            top: 50%;
            left: 0;
            right: 0;
            height: 3px;
            background: #1E64C8;
            z-index: 0;
        }
        
        .timeline-point {
            background: white;
            border: 4px solid #1E64C8;
            border-radius: 50%;
            width: 60px;
            height: 60px;
            display: flex;
            flex-direction: column;
            align-items: center;
            justify-content: center;
            position: relative;
            z-index: 1;
        }
        
        .timeline-point.complete {
            background: #1E64C8;
            color: white;
        }
        
        .timeline-label {
            position: absolute;
            bottom: -40px;
            font-size: 11px;
            font-weight: 600;
            text-align: center;
            width: 100px;
            left: 50%;
            transform: translateX(-50%);
        }
        
        .patent-diagram {
            display: flex;
            flex-direction: column;
            gap: 15px;
            padding: 20px;
        }
        
        .patent-layer {
            display: flex;
            align-items: center;
            gap: 15px;
        }
        
        .patent-icon {
            background: #1E64C8;
            color: white;
            width: 50px;
            height: 50px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-weight: 700;
            font-size: 20px;
            flex-shrink: 0;
        }
        
        .patent-text {
            background: white;
            border: 2px solid #1E64C8;
            border-radius: 8px;
            padding: 12px 15px;
            flex-grow: 1;
            font-size: 14px;
            font-weight: 600;
            color: #1E64C8;
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="main-title">Drug Repurposing</div>
        <div class="subtitle">Strategies and Approaches for Discovering New Uses of Existing Drugs</div>
        
        <div class="content-grid">
            <div class="content-card">
                <div class="content-main">Indication expansion</div>
                <div class="content-desc">New therapeutic uses</div>
            </div>
            <div class="content-card">
                <div class="content-main">Signature matching</div>
                <div class="content-desc">Disease signature comparison</div>
            </div>
            <div class="content-card">
                <div class="content-main">Network propagation</div>
                <div class="content-desc">Disease module identification</div>
            </div>
            <div class="content-card">
                <div class="content-main">Clinical evidence</div>
                <div class="content-desc">Real-world validation</div>
            </div>
            <div class="content-card">
                <div class="content-main">IP considerations</div>
                <div class="content-desc">Patent and exclusivity</div>
            </div>
        </div>

        <!-- Section 1: Indication Expansion -->
        <div class="section">
            <div class="section-title">1. Indication Expansion</div>
            <div class="section-content">
                <div class="diagram">
                    <div class="flow-diagram">
                        <div class="flow-box">Approved Drug<br/>(Original Indication)</div>
                        <div class="flow-arrow">↓</div>
                        <div class="flow-box">Mechanism of Action<br/>Analysis</div>
                        <div class="flow-arrow">↓</div>
                        <div class="flow-box">Related Pathways<br/>Identification</div>
                        <div class="flow-arrow">↓</div>
                        <div class="flow-box">New Indication<br/>(Expanded Use)</div>
                    </div>
                </div>
                <div class="description">
                    <h3>Overview</h3>
                    <p>Indication expansion involves identifying new therapeutic applications for drugs already approved for other conditions. This approach leverages existing safety and pharmacokinetic data, significantly reducing development time and costs.</p>
                    
                    <p>The strategy relies on understanding the drug's mechanism of action and identifying other diseases that share similar molecular pathways or biological targets. This can reduce development time by 3-12 years compared to traditional drug development.</p>
                    
                    <div class="example-box">
                        <h4>Example: Sildenafil (Viagra)</h4>
                        <p>Originally developed for hypertension and angina, sildenafil was later repurposed for erectile dysfunction and subsequently for pulmonary arterial hypertension, demonstrating successful indication expansion.</p>
                    </div>
                    
                    <div class="key-points">
                        <h4>Key Advantages:</h4>
                        <ul>
                            <li>Known safety profile reduces risk</li>
                            <li>Shorter regulatory pathway</li>
                            <li>Lower development costs (50-60% reduction)</li>
                            <li>Faster time to market</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>

        <!-- Section 2: Signature Matching -->
        <div class="section">
            <div class="section-title">2. Signature Matching</div>
            <div class="section-content">
                <div class="diagram">
                    <div class="signature-grid">
                        <div class="signature-box">
                            <div class="signature-title">Disease Signature</div>
                            <div class="gene-list">
                                Gene A ↑<br/>
                                Gene B ↓<br/>
                                Gene C ↑<br/>
                                Gene D ↓<br/>
                                Gene E ↑
                            </div>
                        </div>
                        <div class="match-symbol">⟷</div>
                        <div class="signature-box">
                            <div class="signature-title">Drug Signature</div>
                            <div class="gene-list">
                                Gene A ↓<br/>
                                Gene B ↑<br/>
                                Gene C ↓<br/>
                                Gene D ↑<br/>
                                Gene E ↓
                            </div>
                        </div>
                    </div>
                    <div style="text-align: center; margin-top: 20px; font-weight: 600; color: #4caf50;">
                        Opposite Signatures = Therapeutic Potential
                    </div>
                </div>
                <div class="description">
                    <h3>Overview</h3>
                    <p>Signature matching uses computational approaches to compare gene expression patterns between diseases and drug effects. The goal is to find drugs whose expression signatures are inversely correlated with disease signatures.</p>
                    
                    <p>This method utilizes large-scale gene expression databases like the Connectivity Map (CMap) and LINCS L1000, which contain expression profiles of thousands of drugs across multiple cell lines.</p>
                    
                    <div class="example-box">
                        <h4>Example: Topiramate for Inflammatory Bowel Disease</h4>
                        <p>Computational signature matching identified topiramate, an antiepileptic drug, as a potential treatment for IBD based on inverse gene expression patterns, later validated in preclinical studies.</p>
                    </div>
                    
                    <div class="key-points">
                        <h4>Key Components:</h4>
                        <ul>
                            <li>Disease gene expression profiling</li>
                            <li>Drug-induced expression changes</li>
                            <li>Correlation analysis algorithms</li>
                            <li>Statistical validation methods</li>
                            <li>Experimental verification requirements</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>

        <!-- Section 3: Network Propagation -->
        <div class="section">
            <div class="section-title">3. Network Propagation</div>
            <div class="section-content">
                <div class="diagram">
                    <div class="network-diagram">
                        <div class="network-node">Gene A</div>
                        <div class="network-node">Gene B</div>
                        <div class="network-node">Gene C</div>
                        <div class="network-node">Protein X</div>
                        <div class="central-node">Disease Module</div>
                        <div class="network-node">Protein Y</div>
                        <div class="network-node">Drug Target 1</div>
                        <div class="network-node">Drug Target 2</div>
                        <div class="network-node">Pathway Z</div>
                    </div>
                    <div style="text-align: center; margin-top: 20px; font-size: 14px; color: #666;">
                        Network-based approach identifies drug targets connected to disease modules
                    </div>
                </div>
                <div class="description">
                    <h3>Overview</h3>
                    <p>Network propagation leverages biological network data (protein-protein interactions, metabolic pathways, signaling cascades) to identify disease modules and potential drug targets within these interconnected systems.</p>
                    
                    <p>This approach uses algorithms to propagate information through molecular networks, starting from known disease genes to identify proximal drug targets that may not be immediately obvious from traditional analyses.</p>
                    
                    <div class="example-box">
                        <h4>Example: Metformin for Cancer</h4>
                        <p>Network analysis revealed that metformin, a diabetes drug, affects multiple pathways connected to cancer metabolism and proliferation, leading to clinical trials for cancer prevention and treatment.</p>
                    </div>
                    
                    <div class="key-points">
                        <h4>Key Methodologies:</h4>
                        <ul>
                            <li>Protein-protein interaction networks</li>
                            <li>Random walk algorithms</li>
                            <li>Module identification techniques</li>
                            <li>Network proximity measures</li>
                            <li>Multi-omics data integration</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>

        <!-- Section 4: Clinical Evidence -->
        <div class="section">
            <div class="section-title">4. Clinical Evidence</div>
            <div class="section-content">
                <div class="diagram">
                    <div class="timeline">
                        <div class="timeline-point complete">
                            <div style="font-size: 20px;">✓</div>
                            <div class="timeline-label">Discovery</div>
                        </div>
                        <div class="timeline-point complete">
                            <div style="font-size: 20px;">✓</div>
                            <div class="timeline-label">Preclinical</div>
                        </div>
                        <div class="timeline-point complete">
                            <div style="font-size: 20px;">✓</div>
                            <div class="timeline-label">Phase I</div>
                        </div>
                        <div class="timeline-point complete">
                            <div style="font-size: 20px;">✓</div>
                            <div class="timeline-label">Phase II</div>
                        </div>
                        <div class="timeline-point">
                            <div style="font-size: 20px; color: #1E64C8;">3</div>
                            <div class="timeline-label">Phase III</div>
                        </div>
                        <div class="timeline-point">
                            <div style="font-size: 20px; color: #1E64C8;">✓</div>
                            <div class="timeline-label">Approval</div>
                        </div>
                    </div>
                    <div style="margin-top: 60px; text-align: center; font-weight: 600; color: #1E64C8;">
                        Accelerated pathway for repurposed drugs
                    </div>
                </div>
                <div class="description">
                    <h3>Overview</h3>
                    <p>Clinical evidence for drug repurposing can come from multiple sources including real-world evidence, electronic health records, observational studies, and serendipitous clinical observations.</p>
                    
                    <p>The validation process for repurposed drugs is often faster because safety has already been established. However, efficacy must still be demonstrated through appropriate clinical trials, though these can sometimes skip early safety phases.</p>
                    
                    <div class="example-box">
                        <h4>Example: Thalidomide for Multiple Myeloma</h4>
                        <p>Despite its tragic history, thalidomide was successfully repurposed for multiple myeloma after clinical observations and trials demonstrated significant efficacy, receiving FDA approval in 2006.</p>
                    </div>
                    
                    <div class="key-points">
                        <h4>Evidence Sources:</h4>
                        <ul>
                            <li>Electronic health records (EHR) mining</li>
                            <li>Real-world data analysis</li>
                            <li>Case reports and observational studies</li>
                            <li>Phase II/III clinical trials</li>
                            <li>Post-marketing surveillance data</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>

        <!-- Section 5: IP Considerations -->
        <div class="section">
            <div class="section-title">5. IP Considerations</div>
            <div class="section-content">
                <div class="diagram">
                    <div class="patent-diagram">
                        <div class="patent-layer">
                            <div class="patent-icon">1</div>
                            <div class="patent-text">Original Compound Patent (Expired or Expiring)</div>
                        </div>
                        <div class="patent-layer">
                            <div class="patent-icon">2</div>
                            <div class="patent-text">New Use/Method of Treatment Patent</div>
                        </div>
                        <div class="patent-layer">
                            <div class="patent-icon">3</div>
                            <div class="patent-text">New Formulation Patent</div>
                        </div>
                        <div class="patent-layer">
                            <div class="patent-icon">4</div>
                            <div class="patent-text">Combination Therapy Patent</div>
                        </div>
                        <div class="patent-layer">
                            <div class="patent-icon">5</div>
                            <div class="patent-text">Data Exclusivity Period</div>
                        </div>
                    </div>
                </div>
                <div class="description">
                    <h3>Overview</h3>
                    <p>Intellectual property strategy is crucial for drug repurposing success. While the original compound patent may have expired, new patents can be obtained for novel uses, formulations, or combination therapies.</p>
                    
                    <p>Companies must carefully navigate the patent landscape to ensure sufficient protection for their investment while adhering to regulatory requirements. Market exclusivity can also be obtained through orphan drug designation or pediatric exclusivity.</p>
                    
                    <div class="example-box">
                        <h4>Example: Aspirin</h4>
                        <p>Though aspirin's compound patent expired long ago, new method-of-use patents have been granted for cardiovascular disease prevention, demonstrating ongoing innovation opportunities in repurposed drugs.</p>
                    </div>
                    
                    <div class="key-points">
                        <h4>IP Strategies:</h4>
                        <ul>
                            <li>Method-of-use patents for new indications</li>
                            <li>New formulation development (extended-release, etc.)</li>
                            <li>Combination therapy patents</li>
                            <li>Orphan drug exclusivity (7 years in US)</li>
                            <li>Pediatric exclusivity extensions (6 months)</li>
                            <li>Data exclusivity periods (varies by region)</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>

        <div style="margin-top: 60px; padding: 30px; background: #e3f2fd; border-radius: 8px; border-left: 6px solid #1E64C8;">
            <h3 style="color: #1E64C8; margin-bottom: 15px; font-size: 24px;">Summary</h3>
            <p style="color: #333; line-height: 1.8; font-size: 16px;">
                Drug repurposing represents a powerful strategy to accelerate therapeutic development by leveraging existing drugs for new indications. By combining computational approaches (signature matching, network propagation) with clinical evidence and strategic IP planning, researchers can identify promising candidates more efficiently than traditional drug development. Success requires integration of multiple data types, rigorous validation, and careful consideration of regulatory and commercial factors.
            </p>
        </div>
    </div>
</body>
</html>